Stockreport

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

Cabaletta Bio, Inc.  (CABA) 
PDF PHILADELPHIA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the firs [Read more]